OpenAlex

Mutation in Abl kinase with altered drug-binding kinetics indicates a novel mechanism of imatinib resistance

Proceedings of the National Academy of Sciences 118(46) (2021)

Agatha Lyczek; Benedict‐Tilman Berger; Aziz M. Rangwala; YiTing Paung; Jessica Tom; Hannah Philipose; Jiaye Guo; Steven K. Albanese; Matthew B. Robers; Stefan Knapp; John D. Chodera; Markus A. Seeliger

New Developments in Chronic Myeloid Leukemia: Implications for Therapy

Iranian Journal of Cancer Prevention InPress(InPress) (2016)

Sanaz Tabarestani; Abolfazl Movafagh

BCR-ABL Kinase Domain mutations - E255K, Y253 H and M351T among Sudanese population with CML

Pharmacophore 12(4) (2021)

Hala Elsir Khair; Abozer Y. Elderdery; Bakri Yousef Nour; Hadeil M. E. Idris; Gamila Ali Attaelmanan; Babker Ahmed Mohamed; Hisham Ali Waggiallah

Effects of Two Common Promoter Polymorphisms of Transforming Growth Factor-β1 on Breast Cancer Risks in Ahvaz, West South of Iran

Iranian Journal of Cancer Prevention InPress(InPress) (2016)

Somayeh Parvizi; Ghorban Mohammadzadeh; Maryam Karimi; Mozhgan Noorbehbahani; Alireza Jafary

Imatinib Efficacy, Safety and Resistance in Iranian Patients with Chronic Myeloid Leukemia: A Review of Literature

International Journal of Hematology-Oncology and Stem Cell Research 15(2) (2021)

Asiyeh Amouei; Nesa Daeian; Seyedeh Sana Khezrnia; Ava Mansouri; Molouk Hadjibabaie

ABL Kinase Domain Mutations in Iranian Chronic Myeloid Leukemia Patients with Resistance to Tyrosine Kinase Inhibitors

Laboratory Medicine 52(2) (2020)

Mahboobeh Shojaei; Hamid Rezvani; Azita Azarkeivan; Behzad Poopak

Epigenetic Modulation of DDIT3 and MGMT Expression Acts Synergistically with Resistance to Imatinib towards CML Disease Progression: A Hospital based Study

Asian Pacific Journal of Cancer Prevention 24(12) (2023)

Gautam Hazarika; Manash Pratim Kalita; Simanta Kalita; Partha Das; Kalpajit Dutta; Lipika Lahkar; Anjanjyoti Rajkonwar; Mohammed Ghaznavi Idris; Vinotsale Khamo; Giriraj Kusre; Subhash Medhi

Novel ABL1 mutation in a Moroccan CML patient with Imatinib resistance

Cancer Genetics 288-289 (2024)

Ihssane El Bouchikhi; Hajar Azami Idrissi; Ahmed Lazraq; Badreddine Elmakhzen; Mohamed Ahakoud; Rhizlane Berrady; Karim Ouldim; Laila Bouguenouch; Mohammed El-Azami-El-Idrissi

Induction of K562 Cell Apoptosis by As4S4 via Down-Regulating miR181

Medical Science Monitor 23 (2017)

Jiangjiang Gong; Shunli Zheng; Lei Zhang; Yi Wang; Jiali Meng

Utilization of Next-Generation Deep Sequencing to Analyze BCR-ABL1 Kinase Domain Mutation for Imatinib-Resistant Chronic Myeloid Leukemia Patients in Vietnam

Journal of Leukemia 05(02) (2017)

Chinh Quoc Duong; Cu Duy Nguyen; Nguyen TT; LV Nguyen; Pham Hq; Trinh HTT; Tran HC; Le TQ; Pham HT; Hong TH; Nguyen Thi Hoang; Truong HN; Bach KQ; Nguyen Ta

Differences in Variants in the Structural Domain of BCR-ABL1 Kinase between Chinese Han and Minority Patients with Chronic Myeloid Leukemia by Sanger Sequencing and Next-Generation Sequencing

Cytogenetic and Genome Research 162(4) (2022)

Dilinazi Abulaiti; Niluopaer Tuerxun; Huan Wang; Abulizi Patiguli; Fang Zhao; Yang Liu; Jianping Hao

Mutation Analysis of ABL1 Gene and its Relation to the Achievement of Major Molecular Response in Indonesian Chronic Myeloid Leukemia Patients

Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine 17(1) (2019)

Reni Widyastuti; Melva Louisa; Ikhwan Rinaldi; Riki Nova; Instiaty Instiaty; Rizky Priambodo

Analysis of Two Mutations in the BCR-ABL Fusion Gene Relevant for Monitoring Chronic Myeloid Leukemia Patients

Biointerface Research in Applied Chemistry 13(3) (2022)

Occurrence of Existing BCR-ABL Baseline Mutations and Associated Haplotype (NmR) Among CML Patients with Diverse IM Response: A Hospital-based Study from North-East India

Biochemical Genetics 62(6) (2024)

Gautam Hazarika; Manash Jyoti Kalita; Partha Pratim Das; Simanta Kalita; Kalpajit Dutta; Lipika Lahkar; Anjanjyoti Rajkonwar; Mohammed Ghaznavi Idris; Vinotsale Khamo; Giriraj Kusre; Subhash Medhi

Utility of T315I mutation in Egyptian patients with chronic myeloid leukemia

Egyptian Journal of Basic and Applied Sciences 11(1) (2024)

Alyaa Mohammed Ghoneem; Eman A. Soliman; Shaimaa El‐Ashwah; Mohammed Ahmed Mohammed Abdallah El-Agdar; Hasan Ahmed Abdel-ghaffar

Case Report: Dual resistance to dasatinib/olverembatinib in accelerated-phase cml: identification of a novel SPECC1L-inserted e8a2 BCR::ABL1 transcript and ABL1 V379I mutation

Frontiers in Oncology 15 (2025)

Jingjing Fu; Yangming Tang; Xueqin Ruan; Runfa Wang; Tong Chen; Li Jiang; Yanli He; Zhihong Xu; Balian Wang; Haiqin Zhang; Jing Zhou; Mei Lan; Hongrui Li